Interplay between polygenic effects and polypharmacy on dementia: An investigation in an elderly Scottish cohort.
Raptis, V.; Mullin, D.; Syed, S.; Deary, I. J.; Cox, S. R.; Russ, T. C.; Luciano, M.
Show abstract
INTRODUCTIONPolygenic Risk Scores for Alzheimer dementia (AD-PRS), a measure of aggregate AD genetic risk and polypharmacy have been associated with dementia. Here, we test their interactions association with future dementia among older adults without baseline neurodegenerative diagnoses. METHODSUsing Cox proportional hazards and mortality-adjusted competing risk regression models we analysed up to 17.5 years all-cause incident dementia in the Lothian Birth Cohort 1936 (n=759, 105 dementia patients). We used polypharmacy (total or nervous-system-acting medications count), AD-PRS, and their interaction as main predictors. RESULTSA non-significant interaction was found between AD-PRS and total polypharmacy (HR=1.06; p=0.15) or nervous-system-acting polypharmacy (HR=0.98; p=0.86) in shaping dementia risk. Omitting interaction, mortality-adjusted models showed significant AD-PRS prediction of dementia (HR [~]1.40; p<0.001), non-significant total (HR=1.03; p=0.49), and nervous-system-acting polypharmacy effects (HR=1.27; p=0.069). DISCUSSIONElucidating the complex interplay between polypharmacy and genetics could improve management of inappropriate medication in older adults genetically prone to dementia/AD.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Association between anticholinergic burden and dementia in UK Biobank 97%
- Late-life onset psychotic symptoms and incident cognitive impairment in people without dementia: modification by genetic risk for Alzheimer’s disease 94%
- A metabolite-based machine learning approach to diagnose Alzheimer's-type dementia in blood: Results from the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort 94%
Similar papers in this journal
Similar papers in this journal
- Little genomic support for cyclophilin A-matrix metalloproteinase-9 pathway as a therapeutic target for cognitive impairment in APOE4 carriers 96%
- Co-localized SNPs Affecting the Expression of Taste Perception Genes are linked to Alzheimer's Disease 95%
- Manifestations of genetic risk for Alzheimer's Disease in the blood: a cross-sectional multi-omic analysis in healthy adults aged 18-90+ 95%
Similar papers in this journal
- Impact of different diagnostic measures on drug class association with dementia progression risk: a longitudinal prospective cohort study 95%
- Sex differences in the association of mild behavioral impairment with cognitive aging 94%
- Liver-specific polygenic risk score is more strongly associated than genome-wide score with Alzheimer’s disease diagnosis in a case-control analysis 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.